Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

St Louis, Missouri

Phase 1 cancer trials in St Louis, MO

101 Phase 1 cancer studies are recruiting participants at sites in St Louis as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

St Louis at a glance

Breast cancer studies recruiting in St Louis

Basic details from each study's public record (the 30 most recently updated of 101). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    Washington University School of Medicine
    Registry record
    NCT06253871 · updated
  2. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study site
    Washington University Medicine
    Registry record
    NCT06270706 · updated
  3. An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    BeOne Medicines
    Study site
    Washington University in St Louis
    Registry record
    NCT07222267 · updated
  4. A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    Washington University School of Medicine
    Registry record
    NCT06827236 · updated
  5. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    Washington University
    Registry record
    NCT07029399 · updated
  6. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Washington University School of Medicine in St. Louis
    Registry record
    NCT06465069 · updated
  7. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Washington University
    Registry record
    NCT07114601 · updated
  8. A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Washington University School of Medicine in St. Louis
    Registry record
    NCT07213791 · updated
  9. Study of XB010 in Subjects With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Siteman Cancer Center
    Registry record
    NCT06545331 · updated
  10. A Phase 1 Study of LNCB74 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    LigaChem Biosciences, Inc.
    Study site
    Washington University, Siteman Cancer Center
    Registry record
    NCT06774963 · updated
  11. A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Terremoto Biosciences Inc.
    Study site
    Washington Univ. School of Medicine
    Registry record
    NCT07109726 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in St Louis, MO on ClinicalTrials.gov.

Lung cancer studies recruiting in St Louis

  1. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    Washington University
    Registry record
    NCT05786924 · updated
  2. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT07020221 · updated
  3. A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Washington University School of Medicine ( Site 0134)
    Registry record
    NCT07227597 · updated
  4. A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    TRIANA Biomedicines, Inc.
    Study site
    Washington University Medical Center
    Registry record
    NCT07491497 · updated
  5. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Siteman Cancer Center
    Registry record
    NCT07397338 · updated
  6. Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sairopa B.V.
    Study site
    Washington University Medical Campus
    Registry record
    NCT05856981 · updated
  7. A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Inc
    Study site
    Washington University School of Medicine
    Registry record
    NCT07094204 · updated
  8. DBC-664 in Adult Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Duboce Biopharmaceuticals, Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT07705035 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in St Louis, MO on ClinicalTrials.gov.

Prostate cancer studies recruiting in St Louis

  1. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Study site
    Washington University
    Registry record
    NCT04221542 · updated
  2. A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Washington University School Of Medicine
    Registry record
    NCT05818683 · updated
  3. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    • Phase 1
    • Ages 18 to 100
    • Male participants
    Sponsor
    Janux Therapeutics
    Study site
    Washington University School of Medicine
    Registry record
    NCT05519449 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in St Louis, MO on ClinicalTrials.gov.

Lymphoma studies recruiting in St Louis

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study sites
    Cardinal Glennon Children's Medical Center · Mercy Hospital Saint Louis · Washington University School of Medicine
    Registry record
    NCT04726241 · updated
  2. Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Siteman Cancer Center-South County · Washington University School of Medicine
    Registry record
    NCT04301076 · updated
  3. A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Nuvalent Inc.
    Study site
    Washington University School of Medicine Siteman Cancer Center
    Registry record
    NCT05384626 · updated
  4. A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BeOne Medicines
    Study site
    Washington University School of Medicine
    Registry record
    NCT06697184 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in St Louis, MO on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in St Louis

  1. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Washington University School of Medicine
    Registry record
    NCT05372614 · updated
  2. Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    Washington University School of Medicine
    Registry record
    NCT06141031 · updated
  3. Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    RayzeBio, Inc.
    Registry record
    NCT07165132 · updated
  4. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    Saint Louis University
    Registry record
    NCT06710756 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in St Louis, MO on ClinicalTrials.gov.

Ask about studies near St Louis

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call